-
1
-
-
34247153413
-
The neuropsychiatry of multiple sclerosis: A review of recent developments
-
Ghaffar O, Feinstein A. The neuropsychiatry of multiple sclerosis: a review of recent developments. Curr Opin Psychiatry 2007;20:278-285.
-
(2007)
Curr Opin Psychiatry
, vol.20
, pp. 278-285
-
-
Ghaffar, O.1
Feinstein, A.2
-
2
-
-
33646832088
-
Are there protective treatments for cognitive decline in MS?
-
Amato MP, Portaccio E, Zipoli V. Are there protective treatments for cognitive decline in MS? J Neurol Sci 2006;245:183-186.
-
(2006)
J Neurol Sci
, vol.245
, pp. 183-186
-
-
Amato, M.P.1
Portaccio, E.2
Zipoli, V.3
-
3
-
-
0025777432
-
Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning
-
Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning Neurology 1991;41:692-696.
-
(1991)
Neurology
, vol.41
, pp. 692-696
-
-
Rao, S.M.1
Leo, G.J.2
Ellington, L.3
Nauertz, T.4
Bernardin, L.5
Unverzagt, F.6
-
4
-
-
38149003882
-
APOE ε4 allele is associated with cognitive impairment in patients with multiple sclerosis
-
Shi J, Zhao C, Vollmer TL, Tyry TM, Kuniyoshi SM. APOE ε4 allele is associated with cognitive impairment in patients with multiple sclerosis. Neurology 2008;70:185-190.
-
(2008)
Neurology
, vol.70
, pp. 185-190
-
-
Shi, J.1
Zhao, C.2
Vollmer, T.L.3
Tyry, T.M.4
Kuniyoshi, S.M.5
-
5
-
-
3142556134
-
Development of biomarkers in multiple sclerosis
-
Bielekova B, Martin R. Development of biomarkers in multiple sclerosis. Brain 2004;127:1463-1478.
-
(2004)
Brain
, vol.127
, pp. 1463-1478
-
-
Bielekova, B.1
Martin, R.2
-
7
-
-
0034005675
-
The age range of risk of developing multiple sclerosis: Evidence from a migrant population in Australia
-
Hammond SR, English DR, McLeod JG. The age range of risk of developing multiple sclerosis: evidence from a migrant population in Australia. Brain 2000;123:968-974.
-
(2000)
Brain
, vol.123
, pp. 968-974
-
-
Hammond, S.R.1
English, D.R.2
McLeod, J.G.3
-
8
-
-
33646563430
-
Treatment of cognitive impairment in multiple sclerosis
-
Pierson SH, Griffin N. Treatment of cognitive impairment in multiple sclerosis. Behav Neurol 2006;17:53-67.
-
(2006)
Behav Neurol
, vol.17
, pp. 53-67
-
-
Pierson, S.H.1
Griffin, N.2
-
9
-
-
8744251003
-
Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis
-
Savettieri G, Messina D, Andreoli V, et al. Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J Neurol 2004;10:1208-1214.
-
(2004)
J Neurol
, vol.10
, pp. 1208-1214
-
-
Savettieri, G.1
Messina, D.2
Andreoli, V.3
-
10
-
-
33847196388
-
APOE ε4 is associated with impaired verbal learning in patients with MS
-
Koutsis G, Panas M, Giogkaraki E, et al. APOE ε4 is associated with impaired verbal learning in patients with MS. Neurology 2007;68:546-549.
-
(2007)
Neurology
, vol.68
, pp. 546-549
-
-
Koutsis, G.1
Panas, M.2
Giogkaraki, E.3
-
11
-
-
0021035886
-
Rating neurological impairment in multiple sclerosis: An expanded disability status scale (EDSS)
-
Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
-
(1983)
Neurology
, vol.33
, pp. 1444-1452
-
-
Kurtzke, J.F.1
|